Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC-free CBD Oil for Agitation in Alzheimer's Disease
NCT04436081Phase 2Unknown
- Sponsor
- Eastern Virginia Medical School
- Start
- Feb 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Alzheimer's disease (AD), Dementia, sponsored by Eastern Virginia Medical School. Status: unknown.
02
Drugs
cannabidiol
03
Conditions
Alzheimer's disease (AD)Dementia
Beyond the preview
Go deeper on NCT04436081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04436081.